Granite Point Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-4,500
| Closed | -$551K | – | 97 |
|
|
2016
Q3 | $551K | Sell |
4,500
-5,500
| -55% | -$673K | 0.22% | 57 |
|
|
2016
Q2 | $1.17M | Buy |
+10,000
| New | +$1.17M | 0.5% | 29 |
|
|
2015
Q3 | – | Sell |
-1,555
| Closed | -$281K | – | 105 |
|
|
2015
Q2 | $281K | Sell |
1,555
-845
| -35% | -$153K | 0.08% | 85 |
|
|
2015
Q1 | $416K | Hold |
2,400
| – | – | 0.15% | 77 |
|
|
2014
Q4 | $444K | Sell |
2,400
-300
| -11% | -$55.5K | 0.21% | 63 |
|
|
2014
Q3 | $448K | Hold |
2,700
| – | – | 0.22% | 67 |
|
|
2014
Q2 | $422K | Sell |
2,700
-1,000
| -27% | -$156K | 0.29% | 66 |
|
|
2014
Q1 | $563K | Sell |
3,700
-6,300
| -63% | -$959K | 0.4% | 75 |
|
|
2013
Q4 | $1.33M | Buy |
+10,000
| New | +$1.33M | 0.22% | 44 |
|